Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Johns Hopkins University
With
National Heart, Lung, and Blood Institute (NHLBI)
This is a program to recruit and screen participants for clinical trials or more detailed observational studies of COPD. There are no interventions or comparative results to be published from this study.
Age
40–100
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 40 years and older, either sex
Mild to moderate COPD (FEV1/Forced vital capacity (FVC) ratio ≤ 0.70, FEV1 30-70% predicted, Diffusing capacity of the lungs for carbon monoxide (DLCO) ≥35% predicted)
On stable maintenance therapy for 2 months
Current or former smoker (patient report of at least a 10 pack-year history)
Ability to understand and willingness to sign consent documents
You may not be if
COPD exacerbation requiring treatment within past 6 weeks
Untreated arterial hypertension (systolic blood pressure \> 140 mm Hg, diastolic blood pressure \> 90 mm Hg)
Decompensated heart failure
Myocardial infarction within past 3 months or ever
Evidence of interstitial, occupational or chronic infectious lung disease
Renal dysfunction
Supplemental oxygen \> 2 liters/m at rest
Failure to keep screening appointments
Clareo Health | Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)
